IONS vs UBER · rev $226.6M vs P/E 18, rev $52.02B
Ionis Pharmaceuticals Inc (IONS) versus Uber Technologies Inc (UBER) — a side-by-side from cached financials, not a winner call.
Ionis Pharmaceuticals Inc (IONS) is a biotechnology company listed on NASDAQ.
Uber Technologies Inc (UBER) is a software - application company listed on NYSE. It is led by Dara Khosrowshahi.
Latest reported IONS revenue for 2024-12-31 was $226.6M. Net income was -$104.3M. Revenue was down 30.2% from 2023-12-31 to 2024-12-31. IONS currently screens at market cap $12.28B.
Latest reported UBER revenue for 2025-12-31 was $52.02B. Net income was $10.05B. Revenue was up 18.3% from 2024-12-31 to 2025-12-31. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
IONS currently screens at market cap $12.28B. UBER currently screens at market cap $144.34B and trailing P/E 17.6.
Not investment advice. Open the IONS and UBER stock pages for the full models.
Not investment advice.